T1	DISO 62 75	daño hepático
#1	AnnotatorNotes T1	C0151763; Liver damage; Pathologic Function
T2	PROC 92 112	nutrición parenteral
#2	AnnotatorNotes T2	C0030547; Parenteral Nutrition; Therapeutic or Preventive Procedure | C0204706; Parenteral alimentation procedure; Therapeutic or Preventive Procedure | C1527385; Parenteral Feeding; Therapeutic or Preventive Procedure
T3	CHEM 117 134	aceite de pescado
#3	AnnotatorNotes T3	C0016157; fish oils; Organic Chemical · Pharmacologic Substance
T4	DISO 174 187	daño hepático
#4	AnnotatorNotes T4	C0151763; Liver damage; Pathologic Function
T5	PROC 204 224	nutrición parenteral
#5	AnnotatorNotes T5	C0030547; Parenteral Nutrition; Therapeutic or Preventive Procedure | C0204706; Parenteral alimentation procedure; Therapeutic or Preventive Procedure | C1527385; Parenteral Feeding; Therapeutic or Preventive Procedure
T6	CHEM 229 243	ácidos omega-3
T7	PROC 340 360	nutrición parenteral
#6	AnnotatorNotes T7	C0030547; Parenteral Nutrition; Therapeutic or Preventive Procedure | C0204706; Parenteral alimentation procedure; Therapeutic or Preventive Procedure | C1527385; Parenteral Feeding; Therapeutic or Preventive Procedure
T8	PROC 411 431	nutrición parenteral
#7	AnnotatorNotes T8	C0030547; Parenteral Nutrition; Therapeutic or Preventive Procedure | C0204706; Parenteral alimentation procedure; Therapeutic or Preventive Procedure | C1527385; Parenteral Feeding; Therapeutic or Preventive Procedure
T9	DISO 434 444	alteración
#8	AnnotatorNotes T9	C0221423; Illness (finding); Sign or Symptom
T10	ANAT 473 482	hepáticos
#9	AnnotatorNotes T10	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T11	PROC 574 576	NP
#10	AnnotatorNotes T11	C0030547; Parenteral Nutrition; Therapeutic or Preventive Procedure | C0204706; Parenteral alimentation procedure; Therapeutic or Preventive Procedure | C1527385; Parenteral Feeding; Therapeutic or Preventive Procedure
T12	PROC 601 615	valores de GGT
#11	AnnotatorNotes T12	C0202035; Gamma glutamyl transferase measurement; Laboratory Procedure
T13	PROC 617 633	fosfasa alcalina
T14	PROC 686 688	NP
#12	AnnotatorNotes T14	C0030547; Parenteral Nutrition; Therapeutic or Preventive Procedure | C0204706; Parenteral alimentation procedure; Therapeutic or Preventive Procedure | C1527385; Parenteral Feeding; Therapeutic or Preventive Procedure
T15	PROC 803 806	GGT
#13	AnnotatorNotes T15	C0202035; Gamma glutamyl transferase measurement; Laboratory Procedure
T16	PROC 851 873	valores de bilirrubina
#14	AnnotatorNotes T16	C0344395; Bilirubin measurement; Laboratory Procedure
T17	CHEM 862 873	bilirrubina
#15	AnnotatorNotes T17	C0005437; Bilirubin; Biologically Active Substance · Organic Chemical
T18	PROC 920 922	NP
#16	AnnotatorNotes T18	C0030547; Parenteral Nutrition; Therapeutic or Preventive Procedure | C0204706; Parenteral alimentation procedure; Therapeutic or Preventive Procedure | C1527385; Parenteral Feeding; Therapeutic or Preventive Procedure
T19	PROC 950 969	ingresado en la UCI
#17	AnnotatorNotes T19	C0583239; Admission to intensive care unit; Health Care Activity
T20	CHEM 1097 1104	lípidos
#18	AnnotatorNotes T20	C0023779; Lipids; Organic Chemical
T21	DISO 1108 1115	Alergia
#19	AnnotatorNotes T21	C1527304; Allergic Reaction; Pathologic Function
T22	PROC 1150 1152	NP
#20	AnnotatorNotes T22	C0030547; Parenteral Nutrition; Therapeutic or Preventive Procedure | C0204706; Parenteral alimentation procedure; Therapeutic or Preventive Procedure | C1527385; Parenteral Feeding; Therapeutic or Preventive Procedure
T23	PROC 1169 1184	NP domiciliaria
#21	AnnotatorNotes T23	C0079543; Parenteral Nutrition, Home; Therapeutic or Preventive Procedure
T24	PROC 1187 1206	Trasplante hepático
#22	AnnotatorNotes T24	C0023911; Transplantation of liver; Therapeutic or Preventive Procedure
T25	PROC 1209 1252	Valores bioquímicos de parámetros hepáticos
T26	ANAT 1243 1252	hepáticos
#23	AnnotatorNotes T26	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T27	PROC 1269 1271	NP
#24	AnnotatorNotes T27	C0030547; Parenteral Nutrition; Therapeutic or Preventive Procedure | C0204706; Parenteral alimentation procedure; Therapeutic or Preventive Procedure | C1527385; Parenteral Feeding; Therapeutic or Preventive Procedure
T28	ANAT 67 75	hepático
#25	AnnotatorNotes T28	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T29	ANAT 179 187	hepático
#26	AnnotatorNotes T29	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T30	PROC 265 292	ensayo clínico aleatorizado
#27	AnnotatorNotes T30	C0206034; Clinical Trials, Randomized; Research Activity
T31	PROC 650 661	bilirrubina
#28	AnnotatorNotes T31	C0863174; Blood bilirubin measurement; Laboratory Procedure
T32	PROC 819 837	fosfatasa alcalina
#29	AnnotatorNotes T32	C0201850; Alkaline phosphatase measurement; Laboratory Procedure
T33	PROC 1006 1030	consentimiento informado
#30	AnnotatorNotes T33	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T34	PROC 1079 1093	administración
#31	AnnotatorNotes T34	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T35	ANAT 1198 1206	hepático
#32	AnnotatorNotes T35	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T36	Date 13 17	2019
T37	Route 102 112	parenteral
#33	AnnotatorNotes T37	C1518896; Parenteral Route of Drug Administration; Functional Concept
T38	Route 214 224	parenteral
#34	AnnotatorNotes T38	C1518896; Parenteral Route of Drug Administration; Functional Concept
T39	LIVB 247 263	adultos críticos
#35	AnnotatorNotes T39	C0001675; Adult; Age Group | C0815272; critical populations; Population Group
T40	LIVB 317 335	Pacientes críticos
#36	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group + C0815272; critical population; Population Group
T41	Route 350 360	parenteral
#37	AnnotatorNotes T41	C1518896; Parenteral Route of Drug Administration; Functional Concept
T42	LIVB 388 406	Pacientes críticos
#38	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group + C0815272; critical population; Population Group
T43	Route 421 431	parenteral
#39	AnnotatorNotes T43	C1518896; Parenteral Route of Drug Administration; Functional Concept
T45	LIVB 513 522	Pacientes
#40	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	Age 523 532	≥ 18 años
T47	Duration 555 570	al menos 5 días
T49	Duration 700 715	las 36h previas
T52	Duration 743 758	24h posteriores
T53	Duration 923 931	≥ 5 días
T54	LIVB 936 944	Paciente
#41	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	LIVB 996 1004	paciente
#42	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	LIVB 1156 1164	Paciente
#43	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T59	LIVB 1347 1355	paciente
#44	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	PHYS 46 58	Recuperación
#45	AnnotatorNotes T60	C2004454; Recovery - healing process; Organism Function
T61	PHYS 92 101	nutrición
#46	AnnotatorNotes T61	C1442959; Nutrition function; Organism Function
T62	PHYS 158 170	Recuperación
#47	AnnotatorNotes T62	C2004454; Recovery - healing process; Organism Function
T63	PHYS 204 213	nutrición
#48	AnnotatorNotes T63	C1442959; Nutrition function; Organism Function
T64	PHYS 340 349	nutrición
#49	AnnotatorNotes T64	C1442959; Nutrition function; Organism Function
T65	PHYS 411 420	nutrición
#50	AnnotatorNotes T65	C1442959; Nutrition function; Organism Function
A1	Population_data T39 Age
A4	Assertion T20 Contraindicated
A3	Assertion T34 Contraindicated
A5	Status T21 History_of
A6	Status T24 History_of
#51	AnnotatorNotes T6	C0015689; omega-3 fatty acids; Organic Chemical · Biologically Active Substance
#52	AnnotatorNotes T13	C0201850; Alkaline phosphatase measurement; Laboratory Procedure
R1	Location_of Arg1:T26 Arg2:T25	
T44	CONC 1256 1271	inicio de la NP
R2	Overlap Arg1:T25 Arg2:T44	
T48	Result_or_Value 1272 1330	por encima del 20% del límite superior de valores normales
R3	Has_Result_or_Value Arg1:T25 Arg2:T48	
T50	Observation 1334 1355	Negativa del paciente
R5	Location_of Arg1:T35 Arg2:T24	
R6	Experiences Arg1:T56 Arg2:T23	
R7	Causes Arg1:T22 Arg2:T21	
R8	Used_for Arg1:T20 Arg2:T34	
T51	Observation 981 991	Aceptación
#53	AnnotatorNotes T51	C0600109; Willing; Finding (?)
R10	Overlap Arg1:T51 Arg2:T33	
R11	Experiences Arg1:T54 Arg2:T19	
R12	Has_Duration_or_Interval Arg1:T18 Arg2:T53	
T57	Result_or_Value 807 817	≥ 300 U/dL
R13	Has_Result_or_Value Arg1:T15 Arg2:T57	
T58	Result_or_Value 838 848	≥ 200 U/dL
R14	Has_Result_or_Value Arg1:T32 Arg2:T58	
T66	Result_or_Value 874 884	≥1.8 mg/dL
R15	Has_Result_or_Value Arg1:T16 Arg2:T66	
R16	Has_Duration_or_Interval Arg1:T11 Arg2:T47	
A2	Status T11 History_of
R17	Location_of Arg1:T28 Arg2:T1	
R18	Location_of Arg1:T29 Arg2:T4	
R19	Before Arg1:T1 Arg2:T60	
R20	Before Arg1:T4 Arg2:T62	
R23	Used_for Arg1:T3 Arg2:T2	
R24	Used_for Arg1:T6 Arg2:T5	
R25	Has_Route_or_Mode Arg1:T3 Arg2:T37	
R27	Experiences Arg1:T39 Arg2:T5	
R28	Experiences Arg1:T39 Arg2:T63	
R29	Overlap Arg1:T1 Arg2:T2	
R30	Overlap Arg1:T4 Arg2:T5	
R31	Experiences Arg1:T39 Arg2:T4	
R32	Experiences Arg1:T39 Arg2:T62	
R33	Has_Route_or_Mode Arg1:T7 Arg2:T41	
R34	Has_Route_or_Mode Arg1:T5 Arg2:T38	
R26	Has_Route_or_Mode Arg1:T8 Arg2:T43	
R36	Experiences Arg1:T40 Arg2:T7	
R37	Experiences Arg1:T40 Arg2:T64	
R38	Experiences Arg1:T42 Arg2:T8	
R39	Experiences Arg1:T42 Arg2:T65	
R40	Has_Age Arg1:T45 Arg2:T46	
T67	Result_or_Value 634 644	< 100 U/dL
R41	Has_Result_or_Value Arg1:T13 Arg2:T67	
T68	Result_or_Value 662 672	<1.2 mg/dL
R42	Has_Result_or_Value Arg1:T31 Arg2:T68	
T69	CONC 676 688	inicio de NP
R43	Overlap Arg1:T31 Arg2:T69	
R44	Overlap Arg1:T13 Arg2:T69	
R45	Overlap Arg1:T12 Arg2:T69	
R46	Overlap Arg1:T31 Arg2:T49	
R47	Overlap Arg1:T13 Arg2:T49	
R48	Overlap Arg1:T12 Arg2:T49	
R49	Overlap Arg1:T12 Arg2:T52	
R50	Overlap Arg1:T13 Arg2:T52	
R51	Overlap Arg1:T31 Arg2:T52	
#54	AnnotatorNotes T50	C4284598; Patient refused to participate; Finding
T70	Observation 434 472	alteración de los patrones bioquímicos
#55	AnnotatorNotes T70	C3648370; laboratory tests nonspecific abnormal findings; Finding (?)
R52	Location_of Arg1:T10 Arg2:T70	
R53	Experiences Arg1:T42 Arg2:T9	
R54	Experiences Arg1:T42 Arg2:T70	
T71	Observation 901 922	continuación de la NP
#56	AnnotatorNotes T71	C0420262; Previous treatment continue; Finding (?)
R9	Overlap Arg1:T8 Arg2:T70	
R21	Experiences Arg1:T42 Arg2:T9	
A7	Experiencer T39 Patient
A8	Experiencer T40 Patient
A9	Experiencer T42 Patient
A10	Experiencer T45 Patient
A11	Experiencer T55 Patient
A12	Experiencer T54 Patient
A13	Status T71 Future
A14	Experiencer T56 Patient
A15	Experiencer T59 Patient
